➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Dow
Colorcon
Mallinckrodt
AstraZeneca

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

Patent: 6,495,517

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,495,517
Title: Cyclooxygenase inhibitor
Abstract:A cyclooxygenase-2-inhibitor containing as an active ingredient a compound having cyclooxygenase-2-inhibitory activity and exhibiting low toxicity that causes only minor side effects. The active compound is represented by the following formula (1) or (1\'): ##STR1## wherein R.sup.1 represents a hydrogen atom or a C1-C3 alkyl group; R.sup.2 represents a hydrogen atom, a hydroxyl group, an organic group capable of being bound through its thiol group within the molecule, or R.sup.1 and R.sup.2 may join to each other to form a single bond; R.sup.3 represents a hydrogen atom, a halogen atom, a C1-C3 alkyl group, a C1-C3 alkoxyl group, a trifluoromethyl group, or a nitro group; each of R.sup.4 and R.sup.5, which may be identical to or different from each other, represents a hydrogen atom, a halogen atom, a C1-C4 alkoxyl group, a trifluoromethyl group, or R.sup.4 and R.sup.5 may join to each other to form a methylenedioxy group.
Inventor(s): Tanaka; Zyunji (Tokyo, JP)
Assignee: A. Natterman & Cie. GmbH (Koln, DE)
Application Number:09/838,125
Patent Claims:see list of patent claims

Details for Patent 6,495,517

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Grifols Usa, Llc PLASBUMIN albumin (human) SOLUTION 101138 1 1994-09-26   Start Trial A. Natterman & Cie. GmbH (Koln, DE) 2018-07-01 search
Baxalta Us Inc. FLEXBUMIN albumin human INJECTION, SOLUTION 101452 1 2014-07-31   Start Trial A. Natterman & Cie. GmbH (Koln, DE) 2018-07-01 search
Csl Behring Ag ALBURX albumin (human) SOLUTION 102366 1 2009-01-06   Start Trial A. Natterman & Cie. GmbH (Koln, DE) 2018-07-01 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Express Scripts
Colorcon
Medtronic
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.